Publications by authors named "Asano Maeda"
Transl Clin Pharmacol
December 2023
Article Synopsis
- Colchicine has gained attention as an FDA-approved anti-inflammatory for cardiovascular diseases, though its low dose of 0.5 mg can cause side effects.
- The drug quickly leaves the bloodstream and enters leukocytes, which helps produce its anti-inflammatory effects.
- This study explores how colchicine behaves in plasma and leukocytes after taking 0.5 mg and 0.25 mg doses, finding that it remains in leukocytes even at lower dosages, potentially reducing side effects.
